Psoralen-ultraviolet A-induced erythema: Sensitivity correlates with the concentrations of psoralen in suction blister fluid

British Journal of Dermatology

Volumn 142, Issue 4, 2000, Pages 733-739

  Yeo, U C ^a   Shin, J H ^a   Yang, J M ^a   Park, K B ^a   Kim, M M ^b   Bok, H S ^b   Lee, E S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

8 methoxypsoralen; Psoralen ultraviolet A; Suction blister fluid

Indexed keywords

METHOXSALEN;

ADOLESCENT; ADULT; ARTICLE; BLISTER; BLOOD LEVEL; CLINICAL ARTICLE; ERYTHEMA; FEMALE; HUMAN; MALE; PHOTOCHEMOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PUVA; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION; VITILIGO;

ADOLESCENT; ADULT; BLISTER; ERYTHEMA; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PUVA THERAPY; SENSITIVITY AND SPECIFICITY;

EID: 0034048799     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03419.x     Document Type: Article

References (32)

1. 1 McLelland J, Fisher C, Farr PM et al. The relationship between plasma psoralen concentration and psoralen-UVA erythema. Br J Dermatol 1991; 124: 585-90.
2. 2 Stern RS, Momtaz K. Skin typing for assessment of skin cancer risk and acute response to UVB and oral methoxsalen photochemotherapy. Arch Dermatol 1984; 120: 869-73.
3. 3 Cox NH, Farr PM, Diffey BL. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema. Arch Dermatol 1989; 125: 1653-7.
4. 4 Diffey BL, Farr PM. The normal range in diagnostic phototesting. Br J Dermatol 1989; 120: 517-24.
5. 5 Beani JC, Sarrazin C, Amblard P et al. Comparison between plasma levels of 8-methoxypsoralen and skin photosensitivity: the interest of pharmacokinetic studies during photochemotherapy of psoriasis. Dermatologica 1983; 166: 169-74.
6. 6 Sakuntabhai A, Farr PM, Diffey BL. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity. Br J Dermatol 1993; 128: 561-5.
7. 7 Stevenson IH, Kenicer KJA, Johnson BE, Frain-Bell W. Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis. Br J Dermatol 1981; 104: 47-51.
8. 8 Ljunggren B, Bjellerup M, Carter DM. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UVA in man. J Invest Dermatol 1981; 76: 73-5.
9. 9 Goldstein DP, Carter DM, Ljunggren B, Burkholder J. Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients. J Invest Dermatol 1982; 78: 429-33.
10. 10 Moris WL. Psoralen and UVA radiation. In: Photochemotherapy and Photochemotherapy of Skin Disease (Moris WI, ed.), 2nd edn. New York: Raven Press, 1991: 43-52.
11. 11 Makki S, Treffel P, Humbert P, Agache P. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans. J Chromatogr 1991; 563: 407-13.
12. 12 Mays DC, Nawoot S, Hilliard JB et al. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat. J Pharmacol Exp Ther 1987; 243: 227-33.
13. 13 Farr PM, Diffey BL. The erythemal response of human skin to ultraviolet radiation. Br J Dermatol 1985; 113: 65-76.
14. 14 Pathak MA, Dall'Acqua F, Rodighiero G, Parrish JA. Metabolism of psoralens. J Invest Dermatol 1974; 62: 347 (Abstr.).
15. 15 Lauharanta J, Juvakoski T, Kanerva L, Lassus A. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. Arch Dermatol Res 1982; 273: 111-14.
16. 16 Herfst MJ, Edelbroek PM, de Wolff FA. Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography. Clin Chem 1980; 26: 1825-8.
17. 17 Reymond JL, Beani JC, Racinet H et al. Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid. Photodermatology 1988; 5: 51-2.
18. 18 Herfst MJ, de Wolff FA. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients. Clin Pharmacol Ther 1983; 34: 117-24.
19. 19 Kornhauser A, Wamer WG, Giles AL. Psoralen phototoxicity: correlation with serum and epidermal 8-methoxypsoralen and 5-methoxypsoralen in the guinea pig. Science 1982; 217: 733-5.
20. 20 Korting HC, Schäfer-Korting M, Roser-Maass E, Mutschler E. Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method. Arch Dermatol Res 1982; 272: 9-20.
21. 21 Swanbeck G, Ehrsson H, Ehrnebo M et al. Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis. Clin Pharmacol Ther 1979; 25: 478-80.
22. 22 Midden WR. Chemical mechanisms of bioeffects of furocoumarins: the role of reactions with proteins, lipids and other cellular constituents. In: Psoralen DNA Photobiology (Gasparro FP, ed.). Boca Raton: CRC Press, 1988; 1-19.
23. 23 Caffieri S, Tamborini G, Dall'Acqua F. Formation of photoadducts between unsaturated fatty acids and furocoumarins. Med Biol Environ 1987; 15: 11-14.
24. 24 Pathak MA. Mechanisms of psoralen photosensitization reactions. Natl Cancer Inst Monogr 1984; 66: 41-66.
25. 25 Potapenko AYa. Mechanisms of photodynamic effects of furocoumarins. J Photochem Photobiol Biol 1991; 9: 1-33.
26. 26 de Mol NJ, Beijersbergen van Henegouwen GM, van Beele B. Relation between some photobiological properties of furocoumarins and their extent of singlet oxygen production. Photochem Photobiol 1981; 33: 815-19.
27. -) by psoralens and ultraviolet radiation (320-400 nm). Biochim Biophys Acta 1984; 798: 115-26.
28. 28 Olack G, Gattolin P, Gasparro FP. Improved high-performance liquid chromatographic analysis of 8-methoxypsoralen monoadducts and cross-links in polynucleotide. DNA, and cellular systems: analysis of split-dose protocol. Photochem Photobiol 1993; 57: 941-9.
29. 29 Tokura Y, Edelson RL, Gasparro FP. Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids. J Invest Dermatol 1991; 96: 942-9.
30. 30 de Wolff FA, Thomas TV. Clinical pharmacokinetics of methoxsalen and other psoralens. Clin Pharmacokinetics 1986; 11: 62-75.
31. 31 Vermeer BJ, van Reman FC, Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979; 73: 303-5.
32. 32 Herfst MJ, Rees H. Suction blister fluid as a model for interstitial fluid in rats. Arch Dermatol Res 1978; 263: 325-34.